EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir

Brandon F Keele iD, Afam A Okoye, Christine M Fennessey, Benjamin Varco-Merth, Taina T Immonen, Emek Kose, Andrew Conchas, Mykola Pinkevych, Leslie Lipkey, Laura Newman, Agatha Macairan, Marjorie Bosche und 16 weitere

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Brandon F Keele und 27 weiteren Autor:innen. Beteiligte Einrichtung: AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America. Hauptthemen laut MEDLINE: Simian Acquired Immunodeficiency Syndrome, Simian Immunodeficiency Virus, HIV Infections. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rebound competent viral reservoir (RCVR)–virus that persists during antiretroviral treatment (ART) and can reignite systemic infection when treatment is stopped–is the primary barrier to eradicating HIV. We used time to initiation of ART during primary infection of rhesus macaques (RMs) after intravenous challenge with barcoded SIVmac239 as a means to elucidate the dynamics of RCVR establishment in groups of RMs by creating a multi-log range of pre-ART viral loads and then assessed viral time-to-rebound and reactivation rates resulting from the discontinuation of ART after one year. RMs started on ART on days 3, 4, 5, 6, 7, 9 or 12 post-infection showed a nearly 10-fold difference in pre-ART viral measurements for successive ART-initiation timepoints. Only 1 of 8 RMs initiating ART on days 3 and 4 rebounded after ART interruption despite measurable pre-ART plasma viremia. Rebounding plasma from the 1 rebounding RM contained only a single barcode lineage detected at day 50 post-ART. All RMs starting ART on days 5 and 6 rebounded between 14- and 50-days post-ART with 1–2 rebounding variants each. RMs starting ART on days 7, 9, and 12 had similar time-to-measurable plasma rebound kinetics despite multiple log differences in pre-ART plasma viral load (pVL), with all RMs rebounding between 7- and 16-days post-ART with 3–28 rebounding lineages. Calculated reactivation rates per pre-ART pVL were highest for RMs starting ART on days 5, 6, and 7 after which the rate of accumulation of the RCVR markedly decreased for RMs treated on days 9 and 12, consistent with multiphasic establishment and near saturation of the RCVR within 2 weeks post infection. Taken together, these data highlight the heterogeneity of the RCVR between RMs, the stochastic establishment of the very early RCVR, and the saturability of the RCVR prior to peak viral infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Simian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusHIV InfectionsAnimalsMacaca mulattaVirus ReplicationAnti-Retroviral AgentsViral Load

Substanzen

Anti-Retroviral Agents

Autor:innen und Institutionen

  • AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
  • Infection Analytics Program, Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, Australia.

ORCID-Profile: Brandon F Keele

Förderung

  • NIH HHS
  • NCI NIH HHS
  • NIAID NIH HHS
  • Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
  • Oregon National Primate Research Center
  • National Cancer Institute

Zitieren

APA

Keele, B. F., Okoye, A. A., Fennessey, C. M., Varco-Merth, B., Immonen, T. T., Kose, E., Conchas, A., Pinkevych, M., Lipkey, L., Newman, L., Macairan, A., Bosche, M., Bosche, W. J., Berkemeier, B., Fast, R., Hull, M., Oswald, K., Shoemaker, R., Silipino, L., …, & Picker, L. J. (2024). Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012135

Vancouver

Keele BF, Okoye AA, Fennessey CM, Varco-Merth B, Immonen TT, Kose E, et al. Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012135

BibTeX
@article{Keele2024,
  author = {Keele, Brandon F and Okoye, Afam A and Fennessey, Christine M and Varco-Merth, Benjamin and Immonen, Taina T and Kose, Emek and Conchas, Andrew and Pinkevych, Mykola and Lipkey, Leslie and Newman, Laura and Macairan, Agatha and Bosche, Marjorie and Bosche, William J and Berkemeier, Brian and Fast, Randy and Hull, Mike and Oswald, Kelli and Shoemaker, Rebecca and Silipino, Lorna and Gorelick, Robert J and Duell, Derick and Marenco, Alejandra and Brantley, William and Smedley, Jeremy and Axthelm, Michael and Davenport, Miles P and Lifson, Jeffrey D and Picker, Louis J},
  title = {Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012135}
}
Kostenlos starten →